Montreal Heart Institute
Montreal, Quebec, Canada
Hospital in Montreal, Quebec
5000 Rue Bélanger, Montréal, QC H1T 1C8
153 Beds
About Montreal Heart Institute
The Montreal Heart Institute, in Montreal, Quebec, is a specialty hospital dedicated to the development of cardiology, which is affiliated with the Université de Montréal.
There are 153 beds in Montreal Heart Institute.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Montreal Heart Institute
55
Abbott Medical Devices
14
Ottawa Heart Institute Research Corporation
13
Medtronic Cardiac Rhythm and Heart Failure
9
Icahn School of Medicine at Mount Sinai
8
Pfizer
8
Duke University
6
Biosense Webster, Inc.
4
Population Health Research Institute
4
Forest Laboratories
3
Gilead Sciences
3
Clinical Trials at Montreal Heart Institute
During the past decade, Montreal Heart Institute conducted 110 clinical trials. In the 10-year time frame, 110 clinical trials started and 50 clinical trials were completed, i.e. on
average, 45.5% percent of trials that started reached the finish line to date. In the past 5 years, 39 clinical trials started and 21 clinical trials were completed. i.e. 53.8%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Efficacy and Safety of Azimilide in the Prophylactic Treatment of Patients With Atrial Fibrillation.
2000-12-01
2004-01-01
Completed
431
Efficacy and Safety of Azimilide for the Treatment of Patients With Atrial Fibrillation
2000-09-01
2003-10-01
Completed
446
Efficacy and Safety Evaluation of Azimilide Dihydrochloride in Patients With Implantable Cardioverter Defibrillators
2001-09-01
2004-04-01
Completed
633
Warfarin Versus Aspirin in Reduced Cardiac Ejection Fraction (WARCEF) Trial
2002-10-01
2014-07-01
Completed
2,305
Exercise Training Program to Improve Clinical Outcomes in Individuals With Congestive Heart Failure
2003-04-01
2008-07-01
Completed
2,331
Effect of Pexelizumab on All-Cause Mortality and Myocardial Infarction in Patients Undergoing Coronary Artery Bypass Graft Surgery With Cardio-Pulmonary Bypass
2002-01-01
Completed
3,000
A Safety and Efficacy Trial Evaluating the Use of Fondaparinux in Percutaneous Coronary Intervention (PCI)(63133)(WITHDRAWN)
2003-04-01
Withdrawn
300
ARISE - Aggressive Reduction of Inflammation Stops Events
2003-06-01
2006-12-01
Unknown status
6,000
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Montreal Heart Institute" #1 sponsor was "Montreal Heart Institute" with 55 trials, followed by "Abbott Medical Devices" with 14 trials
sponsored, "Ottawa Heart Institute Research Corporation" with 13 trials sponsored, "Medtronic Cardiac Rhythm and Heart Failure" with 9 trials sponsored and "Icahn School of Medicine at Mount Sinai"
with 9 trials sponsored. Other sponsors include 145 different institutions and
companies that sponsored additional 112 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Montreal Heart Institute"
#1 collaborator was "Canadian Institutes of Health Research (CIHR)" with 32 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 21 trials as a collaborator, "Montreal Heart Institute" with 12 trials as a collaborator, "Medtronic" with 7 trials as a collaborator and "National Institute of Neurological Disorders and Stroke (NINDS)" with 6 trials as a collaborator. Other collaborators include 189 different institutions and companies that were
collaborators in the rest 149 trials.
Clinical Trials Conditions at Montreal Heart Institute
According to Clinical.Site data, the most researched conditions in "Montreal Heart Institute" are
"Heart Failure" (33 trials), "Atrial Fibrillation" (28 trials), "Coronary Artery Disease" (24 trials), "Myocardial Infarction" (12 trials) and "Heart Diseases" (8 trials). Many other conditions were trialed in "Montreal Heart Institute" in a lesser frequency.
Clinical Trials Intervention Types at Montreal Heart Institute
Most popular intervention types in "Montreal Heart Institute" are "Drug" (109 trials), "Device" (73 trials), "Procedure" (36 trials), "Other" (34 trials) and "Behavioral" (9 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (34 trials), "placebo" (5 trials), "Apixaban" (4 trials), "Colchicine" (4 trials) and "Ranolazine" (4 trials). Other intervention names were less common.
Clinical Trials Genders at Montreal Heart Institute
The vast majority of trials in "Montreal Heart Institute" are
248 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at Montreal Heart Institute
Currently, there are 67 active trials in "Montreal Heart Institute".
3 are not yet recruiting,
38 are recruiting,
21 are Active, not recruiting,
and 5 are Enrolling by invitation.
In total, there were 147 completed trials in Montreal Heart Institute,
undefined suspended trials,
and 18 terminated clinical trials to date.
Out of the total trials that were conducted in Montreal Heart Institute, 4 "Phase 1"
clinical trials were conducted, 39 "Phase 2" clinical
trials and 68 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 21 trials, and there were
also 76 trials that are defined as “Not Applicable".